Chronic Disease Management: Innovations in Therapeutics, Devices, and Global Markets | PR Newswire [Video]

Emerging Technologies Revolutionize Chronic Disease Management: Insights into Bio-Wearables, Digital Therapeutics, and AI-Driven Solutions

, /PRNewswire/ — According to the latest study from BCC Research, “Chronic Disease Management: Therapeutics, Device Technologies, and Global Markets,” is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.

The report on the global market for chronic disease management spotlights trends from 2023, estimates for 2024, and projections through 2029. It evaluates the market potential for various therapeutics and advanced device technologies, covering pharmaceuticals, biologics, traditional and wearable medical devices, and digital therapeutics. The report also examines market drivers, restraints, opportunities, and the competitive landscape.

One advance in chronic disease management is biowearable technology, as exemplified by Abbott’s FreeStyle Libre. This device allows real-time tracking of biomarkers, such as glucose levels, via smartphone, reducing the frequency of clinic visits and enabling personalized, proactive care. This highlights the growing importance of digital therapeutics and …